Kepos Capital LP Red Hill Biopharma Ltd. Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$3.51 - $6.17 $379,080 - $666,360	-108,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$6.06 - $9.0 $72,720 - $108,000	-12,000 Reduced 10.0%	108,000 $897,000
Q4 2018 Feb 13, 2019	SELL	$5.18 - $9.35 $511,784 - $923,780	-98,800 Reduced 45.16%	120,000 $666,000
Q2 2018 Aug 13, 2018	BUY	$4.82 - $8.53 $1.05 Million - $1.87 Million	218,800 New	218,800 $1.87 Million

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.